Defects in pre-mRNA processing as causes of and predisposition to diseases

DNA and Cell Biology

Volumn 21, Issue 11, 2002, Pages 803-818

  Stoilov, Peter ^a   Meshorer, Eran ^b   Gencheva, Marieta ^a   Glick, David ^b   Soreq, Hermona ^b   Stamm, Stefan ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; ADENOSINE DEAMINASE; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA GLOBIN; CD45 ANTIGEN; CEREBROSIDE SULFATASE; CHLORAMPHENICOL; CYTOCHROME P450; CYTOCHROME P450 27; FIBRILLIN; FUMARYLACETOACETASE; GENTAMICIN; INTEGRIN; MESSENGER RNA PRECURSOR; NEOMYCIN; OLIGONUCLEOTIDE; PORPHOBILINOGEN DEAMINASE; PYRUVATE DEHYDROGENASE; RIBOZYME; TETRACYCLINE; UNCLASSIFIED DRUG;

ACUTE INTERMITTENT PORPHYRIA; BETA THALASSEMIA; CEREBROTENDINOUS XANTHOMATOSIS; COMBINED IMMUNODEFICIENCY; DISEASE PREDISPOSITION; DMPK GENE; FRONTOTEMPORAL DEMENTIA; GENE; GENE EXPRESSION; GENETICS; GLANZMANN DISEASE; HUMAN; INHERITANCE; LEIGH DISEASE; MARFAN SYNDROME; MENKES SYNDROME; METACHROMATIC LEUKODYSTROPHY; MNK GENE; MYOTONIC DYSTROPHY; NF 1 GENE; ONCOGENE; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; RNA SEQUENCE; RNA SPLICING; SANDHOFF DISEASE; SMN1 GENE; SMN2 GENE; SPINAL MUSCULAR ATROPHY; TAU GENE; TRANS SPLICING; TYROSINEMIA;

CELL TRANSFORMATION, NEOPLASTIC; CODON, NONSENSE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, CATALYTIC; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 0036927671     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454902320908450     Document Type: Review

References (189)

1. Akbarian, S., Smith, M.A., and Jones, E.G. (1995). Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Brain Res. 699, 297-304.
2. Andreassi, C., Jarecki, J., Zhou, J., Coovert, D.D., Monani, U.R. Chen, X., Whitney, M., Pollok, B., Zhang, M., Androphy, E., et al. (2001). Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum. Mol. Genet. 10, 2841-2849.
3. Ars, E., Serra, E., De la Luna, S., Estivill, X., and Lazaro, C. (2000a). Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA. Nucleic Acids Res. 28, 1307-1312.
4. Ars, E., Serra, E., Garcia, J., Kruyer, H., Gaona, A., Lazaro, C., and Estivill, X. (2000b). Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum. Mol. Genet. 9, 237-247.
5. BASS, B.L. (2002). RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71, 817-846.
6. Beghini, A., Ripamonti, C.B., Peterlongo, P., Roversi, G., Cairoli, R., Morra, E., and Larizza, L. (2000). RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum. Mol. Genet. 9, 2297-2304.
7. Bentley, D. (1999). Coupling RNA polymerase II transcription with pre-mRNA processing. Curr. Opin. Cell. Biol. 11, 347-351.
8. Boise, L.H., Gonazlez, G.M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G., and Thompson, C.B. (1993). bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
9. Brais, B., Bouchard, J.P., Xie, Y.G., Rochefort, D.L., Chretien, N., Tome, F.M., Lafreniere, R.G., Rommens, J.M., Uyama, E., Nohirao, et al. (1998). Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 18, 164-167.
10. Brennan, C.M., and Steitz, J.A. (2001). HuR and mRNA stability. Cell. Mol. Life Sci. 58, 266-277.
11. Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M., and Baralle, F.E. (2001). Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20, 1774-1784.
12. Caceres, J.F., and Kornblihtt, A.R. (2002). Alternative splicing: Multiple control mechanisms and involvement in human disease. Trends Genet. 18, 186-193.
13. Cartegni, L., Chew, S.L., and Krainer, A.R. (2002). Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285-298.
14. Carthew, R.W. (2001). Gene silencing by double-stranded RNA. Curr. Opin. Cell Biol. 13, 244-248.
15. Catania, M.V., Aronica, E., Yankaya, B., and Troost, D. (2001). Increased expression of neuronal nitric oxide synthease spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord. J. Neurosci. 21, RC148.
16. Celotto, A.M., and Graveley, B.R. (2002). Exon-specific RNAi: A tool for dissecting the functional relevance of alternative splicing. RNA 8, 718-724.
17. Chang, J.G., Hsieh-Li, H.M., Jong, Y.J., Wang, N.M., Tsai, C.H., and Li, H. (2001). Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl. Acad. Sci. USA 98, 9808-9813.
18. Chen, W., Kubota, S., Teramoto, T., Nishimura, Y., Yonemoto, K., and Seyama, Y. (1998). Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5' splice site at the mutant codon in cerebrotendinous xanthomatosis patients. Biochemistry 37, 4420-4428.
19. Chester, A., Scott, J., Anant, S., and Navaratnam, N. (2000). RNA editing: Cytidine to uridine conversion in apolipoprotein B mRNA. Biochim. Biophys. Acta 1494, 1-13.
20. Cooper, T.A., and Mattox, W. (1997). The regulation of splicesite selection, and its role in human disease. Am. J. Hum. Genet. 61, 259-266.
21. Coovert, D.D., Le, T.T., McAndrew, P.E., Strasswlmmer, J., Crawford, T.O., Mendell, J.R., Coulson, S.E., Androphy, E.J., Prior, T.W., and Burghes, A.H. (1997). The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6, 1205-1214.
22. Couch, F.J., and Weber, B.L. (1996). Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum. Mutat. 8, 8-18.
23. Cramer, P., Caceres, J.F., Cazalla, D., Kadener, S., Muro, A.F., Baralle, F.E., and Kornblihtt, A.R. (1999). Coupling of transcription with alternative splicing: RNA polII promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol. Cell 4, 251-258.
24. Cramer, P., Srebrow, A., Kadener, S., Werbajh, S., De la Mata, M., Melen, G., Nogues, G., and Kornblihtt, A.R. (2001). Coordination between transcription and pre-mRNA processing. FEBS Lett. 498, 179-182.
25. Daoud, R., Da Penha Berzaghi, M., Siedler, F., Hubener, M., and Stamm, S. (1999). Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur. J. Neurosci. 11, 788-802.
26. Daoud, R., Mies, G., Kopczyska, A., Oláh, L., Hossmann, K., and Stamm, S. (2002). Ischemia induces a translocation of the splicing factor tra2-betal and changes alternative splicing patterns in the brain. J. Neurosci. 22, 5889-5899.
27. Daoud, R., Stoilov, P., Stoss, O., Hübener, M., Berzaghi, M.D.P., Hartmann, A.M., Olbrich, M., and Stamm, S. (2000). Control of pre-mRNA processing by extracellular signals: From molecular mechanisms to clinical applications. Gene Ther. Mol. Biol. 5, 141-150.
28. Das, S., Levinson, B., Whitney, S., Vulpe, C., Packman, S., and Gitschier, J. (1994). Diverse mutations in patients with Menkes disease often lead to exon skipping. Am. J. Hum. Genet. 55, 883-889.
29. De Meirleir, L., Lissens, W., Benelli, C., Ponsot, G., Desguerre, I., Marsac, C., Rodriguez, D., Saudubray, J.M., Poggi, F., and Liebaers, I. (1994). Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1 alpha mRNA linked to a silent mutation in a large family with Leigh's encephalomyelopathy. Pediatr. Res. 36, 707-712.
30. Dietz, H.C., Valle, D., Francomano, C.A., Kendzior, R.J., Jr., Pyeritz, R.E., and Cutting, G.R. (1993). The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259, 680-683.
31. Dobkin, C., and Bank, A. (1983). A nucleotide change in IVS 2 of a beta-thalassemia gene leads to a cryptic splice not at the site of the mutation. Prog. Clin. Biol. Res. 134, 127-128.
32. Dobkin, C., Pergolizzi, R.G., Bahre, P., and Bank, A. (1983). Abnormal splice in a mutant human beta-globin gene not at the site of a mutation. Proc. Natl. Acad. Sci. USA 80, 1184-1188.
33. Dredge, B.K., Polydorides, A.D., and Darnell, R.B. (2001). The splice of life: Alternative splicing and neurological disease. Nat. Rev. Neurosci. 2, 43-50.
34. Dreyfuss, G., Kim, W.N., and Kataoka, N. (2002). MessengerRNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell. Biol. 3, 195-205.
35. D'Souza, I., and Schellenberg, G.D. (2000). Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusions. J. Biol. Chem. 275, 17700-17709.
36. D'souza, I., Poorkai, P., Hong, M., Nochlin, D., Lee, V.M.Y., Bird, T.D., and Schellenberg, G.D. (1999). Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. USA 96, 5598-5603.
37. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
38. Frischmeyer, P.A., and Dietz, H.C. (1999). Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 8, 1893-1900.
39. Fujimaru, M., Tanaka, A., Choeh, K., Wakamatsu, N., Sakuraba, H., and Isshiki, G. (1998). Two mutations remote from an exon/intron junction in the beta- hexosaminidase beta-subunit gene affect 3′-splice site selection and cause Sandhoff disease. Hum. Genet. 103, 462-469.
40. Gao, Q.S., Memmott, J., Lafyatis, R., Stamm, S., Screaton, G., and Andreadis, A. (2000). Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia. J. Neurochem. 74, 490-500.
41. Ge, H., Si, Y., and Wolffe, A.P. (1998). A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol. Cell 2, 751-759.
42. Gehring, N.H., Frede, U., Neu-Yilik, G., Hundsdorfer, P., Vetter, B., Hentze, M.W., and Kulozik, A.E. (2001). Increased efficiency of mRNA 3′ end formation: A new genetic mechanism contributing to hereditary thrombophilia. Nat. Genet. 28, 389-392.
43. Gerber, A.P., and Keller, W. (2001). RNA editing by base deamination: More enzymes, more targets, new mysteries. Trends Biochem. Sci. 26, 376-384.
44. Gilad, S., Khosravi, R., Shkedy, D., Uziel, T., Ziv, Y., Savitsky, K., Rotman, G., Smith, S., Chessa, L., Jorgensen, T.J., et al. (1996). Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet. 5, 433-439.
45. Goedert, M., Spillantini, M.G., Crowther, R.A., Chen, S.G., Parchi, P., Tabaton, M., Lanska, D.J., Markesbery, W.R., Wilhelmsen, K.C., Dickson, D.W., et al. (1999). Tau gene mutation in familial progressive subcortical gliosis. Nat. Med. 5, 454-457.
46. Goetz, J., Chatton, B., Mattei, M.G., and Kedinger, C. (1996). Structure and expression of the ATFa gene. J. Biol. Chem. 271, 29589-29598.
47. Goodson, M.L., Park, S.O., and Sarge, K.D. (1995). Tissue-dependent expression of heat shock factor 2 isoforms with distinct transcriptional activities. Mol. Cell. Biol. 15, 5288-5293.
48. Gott, J.M., and Emeson, R.B. (2000). Functions and mechanisms of RNA editing. Annu. Rev. Genet. 34, 499-531.
49. Grabowski, P. (1998). Splicing regulation in neurons: Tinkering with cell-specific control. Cell 92, 709-712.
50. Grabowski, P.L., and Black, D.L. (2001). Alternative RNA splicing in the nervous system. Prog. Neurobiol. 65, 289-308.
51. Graveley, B.R. (2000). Sorting out the complexity of SR protein functions. RNA 6, 1197-1211.
52. Graveley, B.R. (2001). Alternative splicing: Increasing diversity in the proteomic world. Trends Genet. 17, 99-108.
53. Habelhah, H., Shah, K., Huang, L., Ostareck-Lederer, A., Burlingame, A.L., Shokat, K.M., Hentze, M.W., and Ronai, Z. (2001). ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell Biol. 3, 325-330.
54. Hanamura, A., Caceres, J.F., Mayeda, A., Franza, B.R., and Krainer, A.R. (1998). Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4, 430-444.
55. Harrison, P.M., Kumar, A., Lang, N., Snyder, M., and Gerstein, M. (2002). A question of size: The eukaryotic proteome and the problems in defining it. Nucleic Acids Res. 30, 1083-1090.
56. Hartmann, A.M., Rujescu, D., Giannakouros, T., Nikolakaki, E., Goedert, M., Mandelkow, E.M., Gao, Q.S., Andreadis, A., and Stamm, S. (2001). Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors. Mol. Cell. Neurosci. 18, 80-90.
57. Hasegawa, M., Smith, M.J., Iijima, M., Tabira, T., and Goedert, M. (1999). FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett. 443, 93-96.
58. Hasegawa, Y., Kawame, H., Ida, H., Ohashi, T., and Eto, Y. (1994). Single exon mutation in arylsulfatase A gene has two effects: Loss of enzyme activity and aberrant splicing. Hum. Genet. 93, 415-420.
59. Hastings, M.L., and Krainer, A.R. (2001). Pre-mRNA splicing in the new millennium. Curr. Opin. Cell Biol. 13, 302-309.
60. Hentze, M.W., and KULOZIK, A.E. (1999). A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96, 307-310.
61. Herbert, A., and Rich, A. (1999). RNA processing and the evolution of eukaryotes. Nat. Genet. 21, 265-269.
62. Herold, A., Suyama, M., Rodrigues, J.P., Braun, I.C., Kutay, U., Carmo-Fonseca, M., Bork, P., and Izaurralde, E. (2000). TAP (NXF1) belongs to a mulfigene family of putative RNA export factors with a conserved modular architecture. Mol. Cell. Biol. 20, 8996-9008.
63. Hertel, K.J., and Maniatis, T. (1998). The function of multisite splicing enhancers. Mol. Cell 1, 449-455.
64. Higgs, D.R., Wood, W.G., Barton, C., and Weatherall, D.J. (1983). Clinical features and molecular analysis of acquired hemoglobin H disease. Am. J. Med. 75, 181-191.
65. Hodges, P.E., Carrico, P.M., Hogan, J.D., O'Neill, K.E., Owen, J.J., Mangan, M., Davis, B.P., Brooks, J.E., and Garrels, J.I. (2002). Annotating the human proteome: The Human Proteome Survey Database (HumanPSD) and an in-depth target database for G protein-coupled receptors (GPCR-PD) from Incyte Genomics. Nucleic Acids Res. 30, 137-141.
66. Hoffmeyer, S., Nurnberg, P., Ritter, H., Fahsold, R., Leistner, W., Kaufmann, D., and Krone, W. (1998). Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am. J. Hum. Genet. 62, 269-277.
67. Hofmann, Y., Lorson, C.L., Stamm, S., Androphy, E.J., and Wirth, B. (2000). Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl. Acad. Sci. USA 97, 9618-9623.
68. Hogenesch, J.B., Ching, K.A., Batalov, S., Su, A.I., Walker, J.R., Zhou, Y., Kay, S.A., Schultz, P.G., and Cooke, M.P. (2001). A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell 106, 413-415.
69. Holland, P.M., Suzanne, M., Campbell, J.S., Noselli, S., and Cooper, J.A. (1997). MKK7 is a stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous. J. Biol. Chem. 272, 24994-24998.
70. Huntsman, M.M., Tran, B.V., Potkin, S.G., Bunney, W.E., JR., and Jones, E.G. (1998). Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc. Natl. Acad. Sci. USA 95, 15066-15071.
71. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
72. Iijima, M., Tabira, T., Poorkaj, P., Schellenberg, G.D., Trojanowski, J.Q., Lee, V.M., Schmidt, M.L., Takahashi, K., Nabika, T., Matsumoto, T., et al. (1999). A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 10, 497-501.
73. Jablonka, S., Schrank, B., Kralewski, M., Rossoll, W., and Sendtner, M. (2000). Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: An animal model for spinal muscular atrophy type III. Hum. Mol. Genet. 9, 341-346.
74. Jacobsen, M., Schweer, D., Ziegler, A., Gaber, R., Schock, S., Schwinzer, R., Wonigeit, K., Lindert, R.B., Kantarci, O., Schaefer-Klein, J., et al. (2000). A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat. Genet. 26, 495-499.
75. Jin, Y., Dietz, H.C., Montgomery, R.A., Bell, W.R., McIntosh, I., Coller, B., and Bray, P.F. (1996). Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. J. Clin. Invest. 98, 1745-1754.
76. Kalbfuss, B., Mabon, S.A., and Misteli, T. (2001). Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17. J. Biol. Chem. 276, 42986-42993.
77. Kamma, H., Potman, D.S., and Dreyfuss, G. (1995). Cell type specific expression of hnRNP proteins. Exp. Cell Res. 221, 187-196.
78. Kaufer, D., Friedman, A., Seidman, S., and Soreq, H. (1998). Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393, 373-377.
79. Kerem, B., and Kerem, E. (1996). The molecular basis for disease variability in cystic fibrosis. Eur. J. Hum. Genet. 4, 65-73.
80. Kim, V.N., and Dreyfuss, G. (2001). Nuclear mRNA binding proteins couple pre-mRNA splicing and post-splicing events. Mol. Cells 12, 1-10.
81. Kim, V.N., Yong, J., Kataoka, N., Abel, L., Diem, M.D., and Dreyfuss, G. (2001). The Y14 protein communicates to the cytoplasm the position of exon-exon junctions. EMBO J. 20, 2062-2068.
82. Korade-Mirnics, Z., Babitzke, P., and Hoffman, E. (1998). Myotonic dystrophy: Molecular windows on a complex etiology. Nucleic Acids Res. 26, 1363-1368.
83. Krawczak, M., Reiss, J., and Cooper, D.N. (1992). The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum. Genet. 90, 41-54.
84. Krecic, A.M., and Swanson, M.S. (1999). hnRNP complexes: Composition, structure, and function. Curr. Opin. Cell Biol. 11, 363-371.
85. Lacerra, G., Sierakowska, H., Carestia, C., Fucharoen, S., Summerton, J., Weller, D., and Kole, R. (2000). Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. Proc. Natl. Acad. Sci. USA 97, 9591-9596.
86. Lan, N., Howrey, R.P., Lee, S.W., Smith, C.A., and Sullenger, B.A. (1998). Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors. Science 280, 1593-1596.
87. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., Fitzhugh, W., et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
88. Le Corre, S., Harper, C.G., Lopez, P., Ward, P., and Catts, S. (2000). Increased levels of expression of an NMDARI splice variant in the superior temporal gyms in schizophrenia. Neuroreport 11, 983-986.
89. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichiou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165.
90. Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, AR., Dreyfuss, G., and Melki, J. (1997). Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 165, 265-269.
91. Lefur, N., Kelsall, S.R., Silvers, W.K., and Mintz, B. (1997). Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: A projected basis for immunotherapy. Proc. Natl. Acad. Sci. USA 94, 5332-5337.
92. Lev-Lehman, E., Evron, T., Broide, R.S., Meshorer, E., Ariel, I., Seidman, S., and SOREQ, H. (2000). Synaptogenesis and myopathy under acetylcholinesterase overexpression. J. Mol. Neurosci. 14, 93-105.
93. Lewin, A.S., and Hauswirth, W.W. (2001). Ribozyme gene therapy: Applications for molecular medicine. Trends Mol. Med. 7, 221-228.
94. Lim, S.R., and Hertel, K.J. (2001). Modulation of SMN pre-mRNA splicing by inhibition of alternative 3′ splice site pairing. J. Biol. Chem. 2, 2.
95. Lin, C., Bristol, L.A., Jin, L., Dykes-Hoberg, M., Crawford, T., Clawson, L., and Rothstein, J.D. (1998). Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589-602.
96. Lin, J., Frints, S., Duhamel, H., Herold, A., Abad-Rodrigues, J., Dotti, C., Izaurralde E., Marynen, P., and Froyen, G. (2001). NXF5, a novel member of the nuclear RNA export factor family, is lost in a male patient with a syndromic form of mental retardation. CURT. Biol. 11, 1381-1391.
97. Liu, H.X., Cartegni, L., Zhang, M.Q., and Krainer, A.R. (2001). A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat. Genet. 27, 55-58.
98. Liu, W., Qian, C., and Francke, U. (1997). Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat. Genet. 16, 328-329.
99. Llewellyn, D.H., Scobie, G.A., Urquhart, A.J.., Whatley, S.D., Roberts, A.G., Harrison, P.R., and Elder, G.H. (1996). Acute intermittent porphyria caused by defective splicing of porphobilinogen deaminase RNA: A synonymous codon mutation at -22 bp from the 5′ splice site causes skipping of exon 3. J. Med. Genet. 33, 437-438.
100. Lombardi, P., Hoffer, M.J., Top, B., De Wit, E., Gevers Leuven, J.A., Frants, R.R., and Havekes, L.M. (1993). An acceptor splice site mutation in intron 16 of the low density lipoprotein receptor gene leads to an elongated, intemalization defective receptor. Atherosclerosis 104, 117-128.
101. Lorson, C.L., and Androphy, E.J. (2000). An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet. 9, 259-265.
102. Lorson, C.L., Hahnen, E., Androphy, E.J., and Wirth, B. (1999). A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 96, 6307-6311.
103. Lu, X., Timchenko, N.A., and Timchenko, L.T. (1999). Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 8, 53-60.
104. Lynch, K.W., and Weiss, A. (2001). A CD45 polymorphism associted with multiple sclerosis disrupts an exonic splicing silencer. J. Biol. Chem. 276, 24341-24347.
105. Maniatis, T., and REED, R. (2002). An extensive network of coupling among gene expression machines. Nature 416, 499-506.
106. Manley, J.L., and Tacke, R. (1996). SR proteins and splicing control. Genes Dev. 10, 1569-1579.
107. Mann, C.J., Honeyman, K., Cheng, A.J., Ly, T., Lloyd, F., Fletcher, S., Morgan, J.E., Partridge, T.A., and Wilton, S.D. (2001). Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc. Natl. Acad. Sci. USA 98, 42-47.
108. Mansfield, S.G., Kole, J., Puttaraju, M., Yang, C.C., Garcia-Blanco, M.A., Cohn, J.A., and Mitchell, L.G. (2000). Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing. Gene Ther. 7, 1885-1895.
109. Maquat, L.E., and Carmichael, G.G. (2001). Quality control of mRNA function. Cell 104, 173-176.
110. McCormick, J.A., Lyons, V., Jacobson, M.D., Noble, J., Diorio, J., Nyirenda, M., Weaver, S., Ester, W., Yau, J.L., Meaney, M.J., et al. (2000). 5′-Heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: Differential regulation of variant transcripts by early-life events. Mol. Endocrinol. 14, 506-507.
111. McEwen, B.S. (1999). Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22, 105-122.
112. McKie, A.B., McHale, J.C., Keen, T.J., Tarttelin, E.E., Goliath, R., Van Lith-Verhoeven, J.J., Greenberg, J., Ramesar, R.S., Hoyng, C.B., Cremers, F.P., et al. (2001). Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum. Mol. Genet. 10, 1555-1562.
113. Meffre, E., Davis, E., Schiff, C., Cunningham-Rundles, C., Ivashkiv, L.B., Staudt, L.M., Young, J.W., and Nussenzweig, M.C. (2000). Circulating human B cells that express surrogate light chains and edited receptors. Nat. Immunol. 1, 207-213.
114. Mendell, J.T., and Dietz, H.C. (2001). When the message goes awry: Disease-producing mutations that influence mRNA content and performance. Cell 107, 411-414.
115. Mercatante, D., and Kole, R. (2000). Modification of alternative splicing pathways as a potential approach to chemotherpy. Pharmacol. Ther. 85, 237-243.
116. Meshorer, E., Erb, C., Gazit, R., Pavlovsky, L., Kaufer, D., Friedman, A., Glick, D., Ben-Arie, N., and Soreq, H. (2002). Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295, 508-512.
117. Messiaen, L., Callens, T., De Paepe, A., Craen, M., and Mortier, G. (1997). Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene. Hum. Genet. 101, 75-80.
118. Minvielle-Sebastia, L., and Keller, W. (1999). mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription. Curr. Opin. Cell Biol. 11, 352-357.
119. Misteli, T., Caceres, J.F., Clement, J.Q., Krainer, A.R., Wilkinson, M.F., and Spector, D.L. (1998). Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J. Cell. Biol. 143, 297-307.
120. Modrek, B., Resch, A., Grasso, C., and Lee, C. (2001). Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 29, 2850-2859.
121. Monani, U.R., Sendtner, M., Coovert, D.D., Parsons, D.W., Andreassi, C., Le, T.T., Jablonka, S., Schrank, B., Rossol, W., Prior, T.W., et al. (2000). The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(_/_) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333-339.
122. Nabors, L.B., Gillespie, G.Y., Harkins, L., and King, P.H. (2001). HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res. 61, 2154-2161.
123. Nakai, K., and Sakamoto, H. (1994). Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene 141, 171-177.
124. Nayler, O., Stamm, S., and Ullrich, A. (1997). Characterization and comparison of four SR protein kinases. Biochem. J. 326, 693-700.
125. Nayler, O., Stratling, W., Bourquin, J.-P., Stagljar, I., Lindemann, L., Jasper, H., Hartmann, A.M., Fackelmayer, F.O., Ullrich, A., and Stamm, S. (1998). SAF-B couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res. 26, 3542-3549.
126. Neubauer, G., King, A., Rappsilber, J., Calvio, C., Watson, M., Ajuh, P., Sleeman, J., Lamond, A., and Mann, M. (1998). Mass spectrometry and EST-database searching allows characterization of the multiprotein spliceosome complex. Nat. Genet. 20, 46-50.
127. Nissim-Rafinia, M., and Kerem, B. (2002). Splicing regulation as a potential genetic modifier. Trends Genet. 18, 123-127.
128. O'Donovan, C., Apweiler, R., and Bairoch, A. (2001). The human proteomics initiative (HPI). Trends Biotechnol. 19, 178-181.
129. Orkin, S.H., Cheng, T.C., Antonarakis, S.E., and Kazazian, H.H., JR. (1985). Thalassemia due to a mutation in the cleavage-polyadenylation signal of the human beta-globin gene. EMBO J. 4, 453-456.
130. Paddison, P.J., Caudy, A.A., and Hannon, G.J. (2002). Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. USA 99, 1443-1448.
131. Pagani, F., Buratti, E., Stuani, C., Bendix, R., Dork, T., and Baralle, F.E. (2002). A new type of mutation causes a splicing defect in ATM. Nat. Genet. 30, 426-429.
132. Palladino, M.J., Keegan, L.P., O'Connell, M.A., and Reenan, R.A. (2000). A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell 102, 437-449.
133. Paul, M.S., and Bass, B.L. (1998). Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA. EMBO J. 17, 1120-1127.
134. Philips, A.V., and Cooper, T.A. (2000). RNA processing and human disease. Cell. Mol. Life Sci. 57, 235-249.
135. Philips, A.V., Timchenko, L.T., and COOPER, T.A. (1998). Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737-741.
136. Phung, T.L., Sowden, M.P., Sparks, J.D., Sparks, C.E., and Smith, H.C. (1996). Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat. Metabolism 45, 1056-1058.
137. Ploos Van Amstel, J.K., Bergman, A.J., Van Beurden, E.A., Roijers, J.F., Peelen, T., Van Den Berg, I.E., Pollthe, B.T., Kvittingen, E.A., and Berger, R. (1996). Hereditary tyrosinemia type 1: Novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; Variability of the genotype-phenotype relationship. Hum. Genet. 97, 51-59.
138. Poort, S.R., Rosendaal, F.R., Reitsma, P.H., and Bertina, R.M. (1996). A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88, 3698-3703.
139. Puttaraju, M., Jamison, S.F., Mansfield, S.G., Garcia-Blanco, M.A., and Mitchell, L.G. (1999). Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat. Biotechnol. 17, 246-252.
140. Rabinovici, R., Kabir, K., Chen, M., Su, Y., Zhang, D., Luo, X., and Yang, J.H. (2001). ADAR1 is involved in the development of microvascular lung injury. Circ. Res. 88, 1066-1071.
141. Raitskin, O., Cho, D.S., Sperling, J., Nishikura, K., and Sperling, R. (2001). RNA editing activity is associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing machinery. Proc. Natl. Acad. Sci. USA 98, 6571-6596.
142. Rave-Harel, N., Kerem, E., Nissim-Rafinia, M., Madjar, I., Goshen, R., Augarten, A., Rahat, A., Hurwitz, A., Darvasi, A., and Kerem, B. (1997). The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am. J. Hum. Genet. 60, 87-94.
143. Reenan, R.A. (2001). The RNA word meets behavior: A to I pre-mRNA editing in animals. Trends Genet. 17, 53-56.
144. Reiss, J., Dorche, C., Stallmeyer, B., Mendel, R.R., Cohen, N., and Zabot, M.T. (1999). Human molybdopterin synthase gene: Genomic structure and mutations in molybdenum cofactor deficiency type B. Am. J. Hum. Genet. 54, 706-711.
145. Rubin, G.M. (2001). Comparing species. Nature 409, 820-821.
146. Rueter, S.M., Dawson, T.R., and Emeson, R.B. (1999). Regulation of alternative splicing by RNA editing. Nature 399, 75-80.
147. Santisteban, I., Arredondo-Vega, F.X., Kelly, S., Loubser, M., Meydan, N., Roifman, C., Howell, P.L., Bowen, T., Weinberg, K.I., Schroeder, M.L. et al. (1995). Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: Implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum. Mol. Genet. 4, 2081-2087.
148. Sato, N., Hori, O., Yamaguchi, A., Lambert, J.C., Chartier-Harlin, M.C., Robinson, P.A., Delacourte, A., Schmidt, A.M., Furuyama, T., Imaizumi, K., et al. (1999). A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue. J. Neurochem. 72, 2498-2505.
149. Savkur, R.S., Philips, A.V., and Cooper, T.A. (2001). Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29, 40-47.
150. Shapira, M., Tur-Kaspa, I., Bosgraaf, L., Livni, N., Grant, A.D., Grisaru, D., Korner, M., Ebstein, R.P., and Soreq, H. (2000). A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum. Mol. Genet. 9, 1273-1281.
151. Shirohzu, H., Yamaza, H., and Fukumaki, Y. (2000). Repression of aberrant splicing in human beta-globin pre-mRNA with HbE mutation by antisense oligoribonucleotide or splicing factor SF2/ASF. Int. J. Hematol. 72, 28-33.
152. Shohami, E., Kaufer, D., Chen, Y., Seidman, S., Cohen, O., Ginzberg, D., Melamed-Book, N., Yirmiya, R., and Soreq, H. (2000). Antisense prevention of neuronal damages following head injury in mice. J. Mol. Med. 78, 228-236.
153. Soreq, H., and Seidman, S. (2001). Acetylcholinesterase - New roles for an old actor. Nat. Rev. Neurosci. 2, 294-302.
154. Sossi, V., Giuli, A., Vitali, T., Tiziano, F., Mirabella, M., Antonelli, A., Neri, G., and Brahe, C. (2001). Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype. Eur. J. Hum. Genet. 9, 113-120.
155. Spillantini, M.G., and Goedert, M. (2001). Tau gene mutations and tau pathology in frontotemporal dementia and parkinsonism linked to chromosome 17. Adv. Exp. Med. Biol. 487, 21-37.
156. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A., and Ghetti, B. (1998). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737-7741.
157. Stamm, S. (2002). Signals and their transduction pathways regulating alternative splicing: A new dimension of the human genome. Hum. Mol. Genet. 11, 2409-2416.
158. Stamm, S., Zhu, J., Nakai, K., Stoilov, P., Stoss, O., and Zhang, M.Q. (2000). An alternative-exon database and its statistical analysis. DNA Cell Biol. 19, 739-756.
159. Stanford, P.M., Halliday, G.M., Brooks, W.S., Kwok, J.B., Storey, C.E., Creasey, H., Morris, J.G., Fulham, M.J., and Schofield, P.R. (2000). Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations. Brain 123, 880-893.
160. Steinmetz, E.J. (1997). Pre-mRNA processing and the CTD of RNA plymerase II: The tail that wags the dog? Cell 89, 491-494.
161. Stickeler, E., Kittrell, F., Medina, D., and Berget, S.M. (1999). Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorgenesis. Oncogene 18, 3574-3582.
162. Stoss, O., Olbrich, M., Hartmann, A.M., Konig, H., Memmott, J., Andreadis, A., and Stamm, S. (2001). The STAR/GSG famly protein rSLM-2 regulates the section of alternative splice sites. J. Biol. Chem. 276, 8665-8673.
163. Stoss, O., Stoilov, P., Daoud, R., Hartmann, A.M., Olbrich, M., and Stamm, S. (2000). Misregulation of pre-mRNA splicing that causes human diseases. Gene Ther. Mol. Biol. 5, 9-28.
164. Tacke, R., and Manley, J.L. (1999). Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11, 358-362.
165. Takuma, H., Kwak, S., Yoshizawa, T., and Kanazawa, I. (1999). Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann. Neurol. 46, 806-815.
166. Tanabe, M., Sasai, N., Nagata, K., Liu, X.D., Liu, P.C., Thiele, D.J., and Nakai, A. (1999). The mammalian HSF4 gene generates both an activator and a repressor of heat shock genes by alternative splicing. J. Biol. Chem. 274, 27845-27856.
167. Tarn, W.-Y., and Steitz, J.A. (1997). Pre-mRNA splicing: The discovery of a new spliceosome doubles the challange. Trends Biol. Sci. 22, 132-137.
168. Tavtigian, S.V., Simard, J., Teng, D.H., Abtin, V., Baumgard, M., Beck, A., Camp, N.J., Carillo, A.R., Chen, Y., Dayananth, P., et al. (2001). A candidate prostate cancer susceptibility gene at chromosome 17p. Nat. Genet. 27, 172-180.
169. Thanaraj, T.A., and Clark, F. (2001). Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions. Nucleic Acids Res. 29, 2581-2593.
170. Timmons, L., and Fire, A. (1998). Specific interference by ingested dsRNA. Nature 395, 854.
171. Tiscornia, G., and Mahadevan, M.S (2000). Myotonic dystrophy: The role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol. Cell 5, 959-967.
172. Tomkins, O., Kaufer, D., Korn, A., Shelef, I., Golan, H., Reichenthal, E., Soreq, H., and Friedman, A. (2001). Frequent blood-brain barrier disruption in the human cerebral cortex. Cell. Mol. Neurobiol. 21, 675-691.
173. Van der Houven van Oordt, W., Diaz-Meco, M.T., Lozano, J., Krainer, A.R., Moscat, J., and Caceres, J.F. (2000). The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J. Cell Biol. 149, 307-316.
174. Varani, L., Spillantini, M.G., Goedert, M., and Varani, G. (2000). Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics. Nucleic Acids Res. 28, 710-719.
175. Vawter, M.P., Frye, M.A., Hemperly, J.J., Vanderputten, D.M., Usen, N., Doherty, P., Saffell, J.L., Issa, F., Post, R.M., Wyatt, R.J., et al. (2000). Elevated concentration of N-CAM VASE isoforms in schizophrenia. J. Psychiatr. Res. 34, 25-34.
176. Veuger, M.J., Honders, M.W., Landegent, J.E., Willemze, R., and Barge, R.M. (2000). High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia. Blood 96, 1517-1524.
177. Vitali, T., Sossi, V., Tiziano, F., Zappata, S., Giuli, A., Paravatou-Petsotas, M., Neri, G., and Brahe, C. (1999). Detection of the survival motor neuron (SMN) genes by FISH: Further evidence for a role for SMN2 in the modulation of disease severity in SMA patients. Hum. Mol. Genet. 8, 2525-2532.
178. Vithana, E.N., Abu-Safieh, L., Allen, M.J., Carey, A., Papaioannou, M., Chakarova, C., Al-Maghtheh, M., Ebenezer, N.D., Willis, C., Moore, A.T., et al. (2001). A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RPll). Mol. Cell 8, 375-381.
179. Watanabe, T., and Sullenger, B.A. (2000). Induction of wildtype p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl. Acad. Sci. USA 97, 8490-8494.
180. Weg-Remers, S., Ponta, H., Herrlich, P., and Konig, H. (2001). Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J. 20, 4194-4203.
181. Weighardt, F., Biamonti, G., and Riva, S. (1996). The role of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. BioEssays 18, 747-756.
182. Xavier, K.A., Eder, P.S., and Giordano, T. (2000). RNA as a drug target: Methods for biophysical characterization and screening. Trends Biotechnol. 18, 349-356.
183. Xie, J., and McCobb, D.P. (1998). Control of alternative splicing of potassium channels by stress hormones. Science 280, 443-446.
184. Yamanaka, S., Balestra, M.E., Ferrell, L.D., Fan, J., Arnold, K.S., Taylor, S., Taylor, J.M., and Innerarity, T.L. (1995). Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA 92, 8483-8487.
185. Yu, L., Heere-Ress, E., Boucher, B., Defesche, J.C., Kastelein, J., Lavoie, M.A., and Genest, J., JR. (1999). Familial hypercholesterolemia. Acceptor splice site (G → C) mutation in intron 7 of the LDL-R gene: Alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(_1)G → C]. Atherosclerosis 146, 125-131.
186. Zamore, P.D. (2001). RNA interference: Listening to the sound of silence. Nat. Struct. Biol. 8, 746-750.
187. Zhang, Q.X., Hilsenbeck, S.G., Fuqua, S.A., and Borg, A. (1996). Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J. Steroid Biochem. Mol. Biol. 59, 251-260.
188. Zhang, Y., Zhou, L., and Miller, C.A. (1998). A splicing variant of a death domain protein that is regulated by a mitogen-activated kinase is a substrate for c-Jun N-terminal kinase in the human central nervous system. Proc. Natl. Acad. Sci. USA 95, 2586-2591.
189. Zilch, C.F., Walker, A.M., Timon, M., Goff, L.K., Wallace, D.L., and Beverley, P.C. (1998). A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. Eur. J. Immunol. 28, 22-29.